Detalhe da pesquisa
1.
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy.
Annu Rev Med
; 73: 251-265, 2022 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-34699264
2.
Hsp90α and Hsp90ß together operate a hypoxia and nutrient paucity stress-response mechanism during wound healing.
J Cell Sci
; 128(8): 1475-80, 2015 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25736295
3.
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.
Sci Immunol
; 7(72): eabl9330, 2022 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35687697
4.
High potency STING agonists engage unique myeloid pathways to reverse pancreatic cancer immune privilege.
J Immunother Cancer
; 9(8)2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34341132
5.
A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies.
Clin Cancer Res
; 27(11): 3050-3060, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33771853
6.
Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype.
Cancer Immunol Res
; 8(11): 1365-1380, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32917656
7.
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
J Clin Invest
; 128(11): 5137-5149, 2018 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30188869
8.
PRAS40 Connects Microenvironmental Stress Signaling to Exosome-Mediated Secretion.
Mol Cell Biol
; 37(19)2017 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28674187
9.
Breast Cancer MDA-MB-231 Cells Use Secreted Heat Shock Protein-90alpha (Hsp90α) to Survive a Hostile Hypoxic Environment.
Sci Rep
; 6: 20605, 2016 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26846992
10.
The anti-motility signaling mechanism of TGFß3 that controls cell traffic during skin wound healing.
Biol Open
; 1(12): 1169-77, 2012 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23259050